HCA
PRAH

Harbour Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Harbour Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,000
Closed -$457K – 285
2017
Q3 		$457K Sell
6,000
-400
-6% -$30.2K 0.2% 150
2017
Q2 		$480K Buy
+6,400
New +$444K 0.24% 129

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbour Capital Advisors's PRAH Position: Q4 2017 in Review

Harbour Capital Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 6,000 shares — an estimated $457K sold.

Harbour Capital Advisors first reported a position in PRAH in Q2 2017 and held it in 2 quarters. The position peaked at $480K in Q2 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Harbour Capital Advisors reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Harbour Capital Advisors sold 6,000 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $457K.
  • Harbour Capital Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 2 quarters.
  • Harbour Capital Advisors's PRA Health Sciences, Inc. position peaked at $480K in Q2 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Harbour Capital Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.